Breast Cancer
News from the FDA/CDC
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”
From the Journals
Familial cancer risk complex, not limited to same site
“The findings suggest that the familial risk extends to discordant early-onset cancers, including ovarian, testicular, and pancreatic cancers, as...
Conference Coverage
Mammography after breast cancer: No benefit for older patients?
“Ongoing surveillance mammography in these patients may lead to overdiagnosis and overtreatment of cancers that potentially would not harm...
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
From the Journals
Adherence to cancer prevention guidance linked with reduced breast cancer recurrence, death risk
The study population included patients diagnosed with triple-negative breast cancer and HER2-positive breast cancer.
From the Journals
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
From the Journals
The next big thing in cancer research
Despite significant progress, there is still a lot of work to do.
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
From the Journals
Breast cancer screening advice ‘dangerous’ for black women
The current “one-size-fits-all” policy to screen the entire female population from a certain age may be “neither fair and equitable nor optimal...
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.